For The First Time FDA Approves A New Weight Loss Drug

For the first time, since 1999, FDA will approve a new weight loss drug called Qnexa.

On Wednesday morning medical experts voted to endorse Qnexa. Final say is on the Food and Drug Administration, but from the former experiences this is just a formal decision because FDA almost always follows recommended advices from its committees.

For The First Time FDA Approves A New Weight loss Drug For The First Time FDA Approves A New Weight Loss DrugQnexa — is a combination of the anticonvulsant drug topiramate and the appetite suppressant phentermine.

In a clinical trial involving 4,323 people, about 10% of the total body weight was lost in the first year of use. Many users also saw improvements in blood pressure.

Trials also found some side effects like increased heart rate and increased risk of birth defects in women who became pregnant while taking the drug.

More than 35% of American adults are obese, including about 5% who are morbidly obese, and an additional 33% are overweight, according to the Centers for Disease Control and Prevention in Atlanta.

If approved by the FDA, Qnexa would be targeted for people with a body mass index of 30 or above.

Filed Under: Health & Fitness

Comments (1)

Trackback URL | Comments RSS Feed

  1. Ashley says:

    As a society, we should be doing all we can to make sure very few of us ever need the options of surgery or drugs. I don’t think the new pill will produce the desired effect because every expert on obesity and its treatment will tell you that weight loss cannot be achieved without behavior change and in the majority of cases drugs play no part. That’s why I think the new pill is only a good marketing strategy whose primary goal is to fool obese people by promising them miraculous results just as some controversial diets do.

Leave a Reply




If you want a picture to show with your comment, go get a Gravatar.